Zacks Research Brokers Lower Earnings Estimates for Bruker

Bruker Co. (NASDAQ:BRKR - Free Report) - Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for shares of Bruker in a note issued to investors on Monday, April 7th. Zacks Research analyst R. Department now expects that the medical research company will post earnings per share of $0.69 for the quarter, down from their prior forecast of $0.70. The consensus estimate for Bruker's current full-year earnings is $2.69 per share. Zacks Research also issued estimates for Bruker's Q2 2026 earnings at $0.69 EPS, FY2026 earnings at $3.09 EPS and Q1 2027 earnings at $0.66 EPS.

Several other brokerages have also recently commented on BRKR. Guggenheim reiterated a "buy" rating on shares of Bruker in a research report on Monday, February 24th. Citigroup dropped their target price on shares of Bruker from $75.00 to $50.00 and set a "buy" rating for the company in a report on Monday, April 7th. Barclays decreased their price target on shares of Bruker from $60.00 to $50.00 and set an "overweight" rating on the stock in a research note on Thursday. Finally, Stifel Nicolaus dropped their price objective on shares of Bruker from $70.00 to $57.00 and set a "hold" rating for the company in a research note on Friday, February 14th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $66.50.

Bruker Price Performance

NASDAQ:BRKR traded up $0.69 during trading hours on Tuesday, hitting $38.76. 3,139,890 shares of the stock were exchanged, compared to its average volume of 1,467,987. The firm's fifty day moving average price is $46.16 and its 200 day moving average price is $54.75. Bruker has a 52-week low of $34.10 and a 52-week high of $90.03. The company has a market cap of $5.88 billion, a P/E ratio of 51.00, a P/E/G ratio of 2.16 and a beta of 1.18. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15.

Remove Ads

Bruker (NASDAQ:BRKR - Get Free Report) last announced its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%.

Institutional Investors Weigh In On Bruker

Several hedge funds and other institutional investors have recently added to or reduced their stakes in BRKR. London Co. of Virginia grew its holdings in shares of Bruker by 78.4% during the 4th quarter. London Co. of Virginia now owns 4,193,454 shares of the medical research company's stock worth $245,820,000 after purchasing an additional 1,843,294 shares during the period. State Street Corp boosted its stake in Bruker by 9.6% during the third quarter. State Street Corp now owns 3,627,300 shares of the medical research company's stock worth $250,501,000 after buying an additional 318,808 shares during the period. Brown Advisory Inc. increased its position in shares of Bruker by 10.1% during the fourth quarter. Brown Advisory Inc. now owns 2,026,712 shares of the medical research company's stock valued at $118,806,000 after acquiring an additional 185,912 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Bruker by 1.0% in the 4th quarter. Geode Capital Management LLC now owns 2,013,741 shares of the medical research company's stock valued at $118,081,000 after acquiring an additional 20,273 shares during the period. Finally, FIL Ltd lifted its holdings in shares of Bruker by 262.3% in the 4th quarter. FIL Ltd now owns 1,961,416 shares of the medical research company's stock worth $114,978,000 after acquiring an additional 1,420,102 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company's stock.

Bruker Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Monday, March 17th were given a $0.05 dividend. The ex-dividend date was Monday, March 17th. This represents a $0.20 annualized dividend and a yield of 0.52%. Bruker's payout ratio is 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.